Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesBreakthrough cancer pain: Review of prevalence, characteristics and management
Indian Journal of Palliative Care, 09/30/09
Mishra S et al. – Breakthrough pain has been associated with a reduced likelihood of adequate pain control. Despite the large and variable incidence of this phenomenon due to varied definitions of this type of pain, only a few studies have been conducted to assess and effectively treat breakthrough pain though the importance of managing breakthrough pain has been acknowledged by all. A large number of drugs from various classes and novel methods of administration like nasal and transmucosal buccal route, as in the case of fentanyl, have been used in these studies to manage this type of pain. A drug is needed with a quick onset of action and optimal duration that matches the characteristics of breakthrough pain. Some steps have been taken in earlier studies which used nasal formulation of fentanyl as it was found to achieve adequate and quick pain relief. However, further studies are required to confirm this so that in the future we can have as effective protocols for managing breakthrough pain as we have today for managing persistent pain as given by the World Health Organization.
Related Articles
A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial
Current Medical Research and Opinion, 10/08/09
Relevance Score: 80%
The Role of Fentanyl in Cancer-Related Pain
Journal of Palliative Medicine, 10/07/09
Relevance Score: 80%
The Role of OROS Hydromorphone in the Management of Cancer Pain
Pain Practice, 10/27/09
Relevance Score: 79%
Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain
Current Medical Research and Opinion, 10/13/09
Relevance Score: 79%
Core Aspects of Satisfaction with Pain Management: Cancer Patients' Perspectives
Journal of Pain and Symptom Management, 11/02/09
Relevance Score: 68%
Today in Pain Management/Palliative Care...keeping you current
Receive free subspecialty "5-minute updates" via email
Smoking Status and Pain Level Among Head and Neck Cancer Patients
The Journal of Pain, 12/17/09
The Stress Process in Palliative Cancer Care: A Qualitative Study on Informal Caregiving and its Implication for the Delivery of Care
American Journal of Hospice and Palliative Medicine, 12/16/09
Measuring quality of life in pediatric palliative care: challenges and potential solutions
Palliative Medicine, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor